Global Lateral Epicondylitis (Tennis Elbow) Market- Industry
Trends & Forecast Report 2027
The global lateral epicondylitis (tennis elbow) market has reached USD 9,159.73 million in
2020. It is further projected to reach USD 10,734.53 million by 2027, at a CAGR
of 2.30% during the forecast period (2021-2027). The increasing cases of lateral
epicondylitis, along with the increase in the population of age group between
35-60 years and the launch of cost-effective treatment options are the key
drivers for market growth.
Companies in the lateral
epicondylitis market are increasingly investing in R&D for the development
of improved and innovative treatment process technologies, which in turn is driving
the market growth. At the same time, domestic organizations and hospitals are seeking
guidance from international bodies for the diagnosis and treatment of the
condition, which is greatly impacting the global market. The tennis elbow
market is also expected to expand due to the launch of new products that facilitate
the successful treatment of lateral epicondylitis (tennis elbow).Sportspersons
are always at an increased risk of lateral epicondylitis as they have to
perform the same task repetitively. The occurrence of lateral epicondylitis also
depends on the age of the person. It is more common in people between the age
group 35 and 45 as they are more vulnerable to elbow injuries.
Global Lateral Epicondylitis (Tennis Elbow) market overview:
Lateral epicondylitis or tennis elbow is a painful condition, that arises
when tendons are overloaded. This overload is usually caused by repetitive arm movements that place an undue amount of pressure on the arm. Tennis elbow is a
kind of tendinitis that causes tendon swelling and is diagnosed through a
medical examination. If left untreated, it can become debilitating and may also
require surgery. In the case of a tennis elbow injury, the pain occurs where
tendons of the forearm muscle attach to the bony bump. Pain can also spread
from elbow to forearm and wrist. When the affected arm is moved against resistance,
it may have severe consequences. Diagnosis of lateral epicondylitis is performed
via medical imaging tests such as X-ray, an MRI, or electromyography (EMG).Men
and women between the ages of 35 and 60 years are most susceptible to this
Global Lateral Epicondylitis (Tennis Elbow) market forecast and Trends
Cases of Lateral Epicondylitis and Sports-Related Injuries
An increasing population of age group between 35-60, use of improper
equipment by athletes, and strenuous activities of the armature some of the major
factors responsible for lateral epicondylitis (tennis elbow). Additionally, populations
at risk also involve painters, butchers, plumbers, and carpenters. In younger
people, a piece of cartilage or bone in the joints may loosen due to
osteochondritis dissecans leading to lateral epicondylitis. The demand for
available and anticipated treatment for tennis elbow has increased substantially
in recent years, which is driving the growth of the global lateral epicondylitis
Some people think that majority of the tennis elbow injuries are related
to tennis, but only 5% of lateral epicondylitis injuries are related to tennis.
Around 10-15% of tennis players suffer from it at some point in their career.
In the U.S., over 30 million
students participate in organized sports every year, with more than 3.5 million
According to National Safety Council (NSC) around 404,000 injuries were
reported from basketball and 292,000 from football in 2019.
Age group of 5 years to 14 years accounted for almost 44% of total
basketball injuries and 40% of lacrosse and rugby injuries.
This condition tends to affect men and women equally. Half of tennis
players develop pain around the elbow, of which 75% represent true tennis
elbow. It is more common in individuals older than 40 years of age.
In NFL, major league, and NBA, baseball pitchers are at a higher risk of
sustaining elbow injury. Almost 40% of all injured athletes were baseball
pitchers, with more than 20% of all sustained injuries treated via surgery.
Sachin Tendulkar suffered from a tennis elbow injury between 2004-2006.
Tennis players like Andy Murray, Venus Williams, Juan Martin Del Potro,
Aleksandra Wozniak, and NFL great Tom Brady, all have suffered from lateral
epicondylitis in their respective careers.
All these injuries will lead to an increase in the number of diagnosis and
treatment, which will directly contribute towards the growth of lateral
advancement and favorable reimbursement
advancements are one of the major reasons for the increasing global acceptance
of lateral epicondylitis treatment methods. New treatment methods are painless
and help patients recover quickly. Treatment methods will little to no incision
are also being used to treat tennis elbow. Transcatheter arterial embolization
(TAE) and Platelet-rich
plasma (PRP) are innovative treatment methods for tennis elbow. TAE
is an emerging treatment method that uses ultrasound to treat the affected part
whereas PRP is a procedure that entails injecting the person’s platelets into the tendon to
promote healing. Corticosteroid injections are another extensively used method
of treatment for lateral epicondylitis. Short-term use of these injections
poses very few side-effects but long-term use may have some serious consequences.
these innovative methods heal the injury faster with little to no pain and contribute towards the increasing acceptance of the upcoming treatment methods,
which in turn are fueling the growth of the lateral epicondylitis market.
Sluggish Adoption Trend of New Effective Therapies
The low acceptance rate of new effective
therapies is expected to restrict the growth of this market over the coming years.
Though these methods are highly effective in treating the condition, the
devices are highly expensive. Even if the patient does not opt for any kind of
treatment, around 90% of people recover within one year. Since tennis elbow is a
self-limiting condition, it gets healed by itself with complete rest. The injury
has a recovery time of 6 months to 2 years depending upon the rest provided to
the injured part. Most people tend to opt for resting instead of choosing
treatment as it is very expensive. Private
hospital tends to charge an exorbitant fee for the treatment, while only a few
government hospitals have proper facilities to treat the condition. What’s
more, patients often avoid seeking treatment considering the high treatment
costs or inadequate treatment facilities, which is impeding the market growth
for lateral epicondylitis market.
Epicondylitis (Tennis Elbow) Market: Treatment Type
Based on treatment type the global lateral
epicondylitis market is segmented into corticosteroid injection, surgery,
therapy, painkillers, NSAIDs, equipment, and other products. Surgery is often
the last option for treating lateral epicondylitis. This segment includes
treatments such as arthroscopy, open surgeries, and others. Additionally, deep
tissue massage of the forearm is also an effective method to ease the pain and
treat the injured arm. It enhances circulation and combines it with friction
therapy to the tendons on the elbow joint to help it heal faster than just
letting it rest. Additionally, Transcatheter arterial embolization (TAE) is an image-guided,
non-surgical treatment method that reduces irregular blood flow around the
affected area to ease the pain and reduce inflammation. Last but not least. corticosteroids
injections, painkillers & NSAIDs are short-term solutions for the treatment
and some of these may have side-effects as well.
Impact of COVID-19 in the industry
The onset of novel coronavirus has affected
the global economy besides affecting business operations. Due to high infection
rates and adverse impacts on public health systems, various countries had to enforce
nationwide lockdowns, which significantly impacted the development of new
treatment methods, medicines, and related services, as almost 90% of all
clinical trials were either completely shut down or put on hold indefinitely. Industry
players are currently considering digital diagnostic and treatment solutions to
serve the community and provide newfangled opportunities to do business.
the gloomy situation around the globe, major tournaments and competitions were
canceled and are still being canceled. People were forced to stay indoors, resulting
in a decrease in the number of diagnoses and medical treatments for lateral
epicondylitis. As the focus on social-distancing grew, diagnosis, treatment,
and surgeries were put on hold and people were forced to manage the condition
at home with complete rest and over-the-counter medication.
Global Lateral Epicondylitis (Tennis Elbow):
The global market
is segregated into hospital/clinic and pharmacy/drug stores. Tie-ups of
government authorities with the hospitals for players’ safety and insurance are driving the growth of the hospital segment. Additionally, with the integration of the latest
technology and treatment methods, hospitals nowadays prefer providing patients
with percutaneous (smaller incision) surgery. When compared to open surgery
with a wider incision, patients feel considerably less discomfort during
percutaneous surgery conducted using radio wave frequency. Along with innovative
treatment methods that are painless and facilitate faster healing, the aforementioned
factors are driving the demand for lateral epicondylitis treatment.
Lateral Epicondylitis (Tennis Elbow) Market: Regional Insights
The global lateral epicondylitis market is segmented into five regions: North
America, Europe, the Asia-Pacific, Latin America, and the Middle East &
Africa. North American market accounts for a significant share in the global
lateral epicondylitis (tennis elbow) market.
Football is one of the most popular sports in North America followed by
baseball and tennis. The country also hosts the US Open--one of the four Grand Slam
events. Tom Brady(NFL), Tiger Woods(Golf), Serena Williams(Tennis), Allen
Iverson(Basketball) are some of the famous American athletes who suffered from
tennis elbow in their careers. Almost 50% of all injuries sustained by the
players in MLB (Major League Baseball) are arm injuries, as reported by Orthopedic
Journal of Sports Medicine. High disposable income, well-established healthcare infrastructure, the strong financial
position of hospitals, with the presence of leading global market players are
driving the market growth for lateral epicondylitis in North America.
and the Asia-Pacific is expected to grow significantly due to the emergence of
various topical sprays, therapies, and injections
that require little to no incision for the treatment of the condition. Latin
America, along with the Middle East & Africa are also expected to show
appreciable market growth in the forecast period.
The global lateral epicondylitis
(tennis elbow) market is consolidated in nature. Some of the
key players operating in the market include Stryker Corporation, Chugai
Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO
Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company,
Arthrex, and other prominent players. Mergers and acquisitions are some of the
strategies adopted by the key manufacturers. New product launches, along with a
strong focus on continuous technology innovations are also some strategies
adopted by the major players. The companies are also trying to dominate the
market by investing in research and development.
Various companies are striving to gain market
share by adopting competitive strategies such as joint ventures and research
market players compete based on product quality, conformance to standards and
performance, and cost-effective manufacturing process, which in
turn optimizes the process for better production.
injections and physiotherapy were used singly and in combination for lateral
epicondylalgia: a single-blinded randomized clinical trial.
New IR treatment for 'tennis elbow' was launched for reducing pain and
inflammation without surgery.
Platelet-Rich Plasma (PRP) was investigated for its effectiveness in speeding
the healing of a variety of tendon injuries.
Scope of the
Historical data – 2017-2020
Base Year – 2021
Forecast – 2022 – 2027
Revenue in USD Million
U.S, Canada, Germany, UK, France, Italy,
Spain, Brazil, Mexico, Japan, South Korea, China, India, Argentina, AUAE,
South Africa, Saudi Arabia
Type, End-User, and Region
Key players operating in the market include
Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation,
Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith &
Nephew plc, Pfizer Inc., 3M Company, Arthrex, and other prominent players.
Scope of the
By Treatment Type
Ø Corticosteroid Injections
Ø Therapy (Shock Wave Therapy & Physical
Ø Painkillers and NSAIDS
Ø Equipment's and Other Products
Ø Pharmacy/Drug Store
Ø North America
Ø the Asia-Pacific (APAC)
Ø Latin America (LATAM)
Ø the Middle-East & Africa (MEA)
is the current size of the global lateral epicondylitis(tennis elbow) market?
Ans: Current size of the
global lateral epicondylitis (tennis elbow) market is USD 9,159.73 million.
are the major factors driving the growth of the lateral epicondylitis market?
Ans: Increase in the
number of injuries, innovation in technology & treatment type, innovative
methods with little to no incision, government policies, and tie-ups with
hospitals are some of the factors driving the market growth of lateral epicondylitis
(tennis elbow) market.
are the key players in the global lateral epicondylitis (tennis elbow) market?
Ans: Stryker Corporation, Chugai Pharmaceutical Co.,
Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer
Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex, and others
are some of the key players operating in the global lateral epicondylitis
Which end-user segment accounted for the largest market share in the global lateral
accounted for the larger market share in the global lateral epicondylitis
Which region accounted for the largest market share in the global lateral
Ans: North America accounted
for the largest market share in the global lateral epicondylitis market.